Frontera Therapeutics is an AAV gene therapy company with the mission to establish a low-cost and scalable platform, to develop and produce high-quality and affordably priced rAAV therapies for the global market.

Biotechnology

Frontera Therapeutics

Frontera Therapeutics' headquarters in Bedford, MA, United States

Zhong-Dong Shi

梅 薛

Michelle Wang

Chinmay Patkar

Hongbin Xu

Fading Chen

Robert Kotin

Xandra Breakefield

Fraser Wright

Carl Gordon

George Church

Jean Bennett

Mark Kay

Philip Reilly

Glenn Pierce

The Scientific Team at Frontera Therapeutics is responsible for the research and development of innovative AAV gene therapies. They focus on upstream process development, scientific advisory roles, and ensuring the production of high-quality, scalable, and cost-effective rAAV therapies to meet global healthcare needs.

Scientific Team

The Leadership Team at Frontera Therapeutics drives the strategic vision and operational execution of the company. Comprising the Founder & CEO, Principal Associate Scientists, and Principal Scientist, this team oversees the development and production of cost-effective, high-quality rAAV therapies, ensuring alignment with the company's mission to make gene therapy accessible on a global scale.

Leadership Team

��

Frontera Therapeutics

Org chart

Board & advisors

Teams

Scientific Team

Leadership Team

Offices

��������

Frontera Therapeutics

Org chart

Board & advisors

Teams

Scientific Team

Leadership Team

Offices

Related companies

��